Applied health economics and health policy

Keyphrases

Publications

volume 22, number 4, 2024

Muhammad Iftikhar Ul Husnain, Mohammad Hajizadeh, Hasnat Ahmad, Rasheda Khanam
The Hidden Toll of Psychological Distress in Australian Adults and Its Impact on Health-Related Quality of Life Measured as Health State Utilities. Applied health economics and health policy 22 (4) (2024)
Umenthala Srikanth Reddy
Measurement of Catastrophic Health Expenditure in India: A Systematic Review and Meta-Analysis. Applied health economics and health policy 22 (4) (2024)
Stuart James Wright, Ewan Gray, Gabriel Rogers, Anna Donten, Katherine Payne
A structured process for the validation of a decision-analytic model: application to a cost-effectiveness model for risk-stratified national breast screening. Applied health economics and health policy 22 (4) (2024)
Stuart James Wright, Ewan Gray, Gabriel Rogers, Anna Donten, Katherine Payne
A structured process for the validation of a decision-analytic model: application to a cost-effectiveness model for risk-stratified national breast screening. Applied health economics and health policy 22 (4) (2024)
Chiara Malmberg, Magnus Värendh, Patric Berling, Mata Charokopou, Erik Eklund
Cost Effectiveness of Adding Fenfluramine to Standard of Care for Patients with Dravet Syndrome in Sweden. Applied health economics and health policy 22 (4) (2024)
Chiara Malmberg, Magnus Värendh, Patric Berling, Mata Charokopou, Erik Eklund
Cost Effectiveness of Adding Fenfluramine to Standard of Care for Patients with Dravet Syndrome in Sweden. Applied health economics and health policy 22 (4) (2024)
Davene R Wright, Mikaela Batista, Tim Wrightson
#SharingHEOR: Developing Modern Media for Communication and Dissemination of Health Economics and Outcomes Research. Applied health economics and health policy 22 (4) (2024)
Davene R Wright, Mikaela Batista, Tim Wrightson
#SharingHEOR: Developing Modern Media for Communication and Dissemination of Health Economics and Outcomes Research. Applied health economics and health policy 22 (4) (2024)
Mohsen Ghaffari Darab, Lidia Engel, Dennis Henzler, Michael Lauerer, Eckhard Nagel, Vicki Brown, Cathrine Mihalopoulos
Model-Based Economic Evaluations of Interventions for Dementia: An Updated Systematic Review and Quality Assessment. Applied health economics and health policy 22 (4) (2024)
Martin Hensher, Gerry McCartney, Eleanor Ochodo
Health Economics in a World of Uneconomic Growth. Applied health economics and health policy 22 (4) (2024)
Enxue Chang, Haofei Li, Wanji Zheng, Lan Zhou, Yanni Jia, Wen Gu, Yiyin Cao, Xiaoying Zhu, Juan Xu, Bo Liu, Mao You, Kejun Liu, Mingsi Wang, Weidong Huang
Economic Evaluation of COVID-19 Immunization Strategies: A Systematic Review and Narrative Synthesis. Applied health economics and health policy 22 (4) (2024)
Martin Hensher, Gerry McCartney, Eleanor Ochodo
Health Economics in a World of Uneconomic Growth. Applied health economics and health policy 22 (4) (2024)
Ningxin Ding, Huixuan Zhou, Chen Chen, Hui Chen, Yunfeng Shi
Comparison of the Measurement Properties of EQ-5D-5L and SF-6Dv2 in COVID-19 Patients in China. Applied health economics and health policy 22 (4) (2024)
Enxue Chang, Haofei Li, Wanji Zheng, Lan Zhou, Yanni Jia, Wen Gu, Yiyin Cao, Xiaoying Zhu, Juan Xu, Bo Liu, Mao You, Kejun Liu, Mingsi Wang, Weidong Huang
Economic Evaluation of COVID-19 Immunization Strategies: A Systematic Review and Narrative Synthesis. Applied health economics and health policy 22 (4) (2024)

volume 22, number 5, 2024

Paul-Simon Pugliesi, Laurie Marrauld, Catherine Lejeune
Cost of Carbon in the Total Cost of Healthcare Procedures: A Methodological Challenge. Applied health economics and health policy 22 (5) (2024)
Ilana N Ackerman, Richard Norman, Ian A Harris, Kara Cashman, Michelle F Lorimer, Stephen D Gill, Peter L Lewis, Sze-Ee Soh
How Does the New Australian EQ-5D-5L Value Set Impact Utility Scores? Analysis of Data from the Australian Orthopaedic Association National Joint Replacement Registry. Applied health economics and health policy 22 (5) (2024)
Ilana N Ackerman, Richard Norman, Ian A Harris, Kara Cashman, Michelle F Lorimer, Stephen D Gill, Peter L Lewis, Sze-Ee Soh
How Does the New Australian EQ-5D-5L Value Set Impact Utility Scores? Analysis of Data from the Australian Orthopaedic Association National Joint Replacement Registry. Applied health economics and health policy 22 (5) (2024)
Dominic Muston
Informing Structural Assumptions for Three State Oncology Cost-Effectiveness Models through Model Efficiency and Fit. Applied health economics and health policy 22 (5) (2024)
Sabine Vogler, Katharina Habimana, Manuel Alexander Haasis, Stefan Fischer
Pricing, Procurement and Reimbursement Policies for Incentivizing Market Entry of Novel Antibiotics and Diagnostics: Learnings from 10 Countries Globally. Applied health economics and health policy 22 (5) (2024)
Matt Wilkinson-Stokes, Michelle Tew, Celene Y L Yap, Dianne Crellin, Marie Frances Gerdtz
The Economic Impact of Community Paramedics Within Emergency Medical Services: A Systematic Review. Applied health economics and health policy 22 (5) (2024)
Pim Wilhelmus Maria van Dorst, Simon van der Pol, Piero Olliaro, Sabine Dittrich, Juvenal Nkeramahame, Maarten J Postma, Cornelis Boersma, Antoinette D I van Asselt
Cost-Effectiveness of Test-and-Treat Strategies to Reduce the Antibiotic Prescription Rate for Acute Febrile Illness in Primary Healthcare Clinics in Africa. Applied health economics and health policy 22 (5) (2024)
Pim Wilhelmus Maria van Dorst, Simon van der Pol, Piero Olliaro, Sabine Dittrich, Juvenal Nkeramahame, Maarten J Postma, Cornelis Boersma, Antoinette D I van Asselt
Cost-Effectiveness of Test-and-Treat Strategies to Reduce the Antibiotic Prescription Rate for Acute Febrile Illness in Primary Healthcare Clinics in Africa. Applied health economics and health policy 22 (5) (2024)
Paul-Simon Pugliesi, Laurie Marrauld, Catherine Lejeune
Cost of Carbon in the Total Cost of Healthcare Procedures: A Methodological Challenge. Applied health economics and health policy 22 (5) (2024)
Louisa G Collins, Ryan Gage, Craig Sinclair, Daniel Lindsay
The Cost-Effectiveness of Primary Prevention Interventions for Skin Cancer: An Updated Systematic Review. Applied health economics and health policy 22 (5) (2024)
Pim Wilhelmus Maria van Dorst, Simon van der Pol, Piero Olliaro, Sabine Dittrich, Juvenal Nkeramahame, Maarten J Postma, Cornelis Boersma, Antoinette D I van Asselt
Cost-Effectiveness of Test-and-Treat Strategies to Reduce the Antibiotic Prescription Rate for Acute Febrile Illness in Primary Healthcare Clinics in Africa. Applied health economics and health policy 22 (5) (2024)
Matt Wilkinson-Stokes, Michelle Tew, Celene Y L Yap, Dianne Crellin, Marie Frances Gerdtz
The Economic Impact of Community Paramedics Within Emergency Medical Services: A Systematic Review. Applied health economics and health policy 22 (5) (2024)
Louisa G Collins, Ryan Gage, Craig Sinclair, Daniel Lindsay
The Cost-Effectiveness of Primary Prevention Interventions for Skin Cancer: An Updated Systematic Review. Applied health economics and health policy 22 (5) (2024)
Maryia Zhdanava, Jacqueline Pesa, Porpong Boonmak, Samuel Schwartzbein, Qian Cai, Dominic Pilon, Zia Choudhry, Marie-Hélène Lafeuille, Patrick Lefebvre, Nizar Souayah
Predictors of High Healthcare Cost Among Patients with Generalized Myasthenia Gravis: A Combined Machine Learning and Regression Approach from a US Payer Perspective. Applied health economics and health policy 22 (5) (2024)
Theodore Laetsch, Jie Zhang, Hongbo Yang, Yanwen Xie, Dudan Zhang, Louis Garrison
Evolving Evidence-Based Value Assessment of One-Time Therapies: Tisagenlecleucel as a Case Study. Applied health economics and health policy 22 (5) (2024)
Maryia Zhdanava, Jacqueline Pesa, Porpong Boonmak, Samuel Schwartzbein, Qian Cai, Dominic Pilon, Zia Choudhry, Marie-Hélène Lafeuille, Patrick Lefebvre, Nizar Souayah
Predictors of High Healthcare Cost Among Patients with Generalized Myasthenia Gravis: A Combined Machine Learning and Regression Approach from a US Payer Perspective. Applied health economics and health policy 22 (5) (2024)
Margherita Neri, Patricia Cubi-Molla, Graham Cookson
A Multi-dimensional Framework of Valued Output for Primary Care in England. Applied health economics and health policy 22 (5) (2024)
Margherita Neri, Patricia Cubi-Molla, Graham Cookson
A Multi-dimensional Framework of Valued Output for Primary Care in England. Applied health economics and health policy 22 (5) (2024)
Margherita Neri, Patricia Cubi-Molla, Graham Cookson
A Multi-dimensional Framework of Valued Output for Primary Care in England. Applied health economics and health policy 22 (5) (2024)
Ilana N Ackerman, Richard Norman, Ian A Harris, Kara Cashman, Michelle F Lorimer, Stephen D Gill, Peter L Lewis, Sze-Ee Soh
How Does the New Australian EQ-5D-5L Value Set Impact Utility Scores? Analysis of Data from the Australian Orthopaedic Association National Joint Replacement Registry. Applied health economics and health policy 22 (5) (2024)
Maryia Zhdanava, Jacqueline Pesa, Porpong Boonmak, Samuel Schwartzbein, Qian Cai, Dominic Pilon, Zia Choudhry, Marie-Hélène Lafeuille, Patrick Lefebvre, Nizar Souayah
Predictors of High Healthcare Cost Among Patients with Generalized Myasthenia Gravis: A Combined Machine Learning and Regression Approach from a US Payer Perspective. Applied health economics and health policy 22 (5) (2024)
Rungroj Krittayaphong, Unchalee Permsuwan
Employing Real-World Evidence for the Economic Evaluation of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation in Thailand. Applied health economics and health policy 22 (5) (2024)
Matt Wilkinson-Stokes, Michelle Tew, Celene Y L Yap, Dianne Crellin, Marie Frances Gerdtz
The Economic Impact of Community Paramedics Within Emergency Medical Services: A Systematic Review. Applied health economics and health policy 22 (5) (2024)
Theodore Laetsch, Jie Zhang, Hongbo Yang, Yanwen Xie, Dudan Zhang, Louis Garrison
Evolving Evidence-Based Value Assessment of One-Time Therapies: Tisagenlecleucel as a Case Study. Applied health economics and health policy 22 (5) (2024)
Dominic Muston
Informing Structural Assumptions for Three State Oncology Cost-Effectiveness Models through Model Efficiency and Fit. Applied health economics and health policy 22 (5) (2024)
Sabine Vogler, Katharina Habimana, Manuel Alexander Haasis, Stefan Fischer
Pricing, Procurement and Reimbursement Policies for Incentivizing Market Entry of Novel Antibiotics and Diagnostics: Learnings from 10 Countries Globally. Applied health economics and health policy 22 (5) (2024)
Margherita Neri, Patricia Cubi-Molla, Graham Cookson
A Multi-dimensional Framework of Valued Output for Primary Care in England. Applied health economics and health policy 22 (5) (2024)
Rungroj Krittayaphong, Unchalee Permsuwan
Employing Real-World Evidence for the Economic Evaluation of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation in Thailand. Applied health economics and health policy 22 (5) (2024)
Theodore Laetsch, Jie Zhang, Hongbo Yang, Yanwen Xie, Dudan Zhang, Louis Garrison
Evolving Evidence-Based Value Assessment of One-Time Therapies: Tisagenlecleucel as a Case Study. Applied health economics and health policy 22 (5) (2024)
Matt Wilkinson-Stokes, Michelle Tew, Celene Y L Yap, Dianne Crellin, Marie Frances Gerdtz
The Economic Impact of Community Paramedics Within Emergency Medical Services: A Systematic Review. Applied health economics and health policy 22 (5) (2024)
Rituparna Basu, Simon Eggington, Natalie Hallas, Liesl Strachan
Are Medical Device Characteristics Included in HTA Methods Guidelines and Reports? A Brief Review. Applied health economics and health policy 22 (5) (2024)
Ilana N Ackerman, Richard Norman, Ian A Harris, Kara Cashman, Michelle F Lorimer, Stephen D Gill, Peter L Lewis, Sze-Ee Soh
How Does the New Australian EQ-5D-5L Value Set Impact Utility Scores? Analysis of Data from the Australian Orthopaedic Association National Joint Replacement Registry. Applied health economics and health policy 22 (5) (2024)
Theodore Laetsch, Jie Zhang, Hongbo Yang, Yanwen Xie, Dudan Zhang, Louis Garrison
Evolving Evidence-Based Value Assessment of One-Time Therapies: Tisagenlecleucel as a Case Study. Applied health economics and health policy 22 (5) (2024)
Pim Wilhelmus Maria van Dorst, Simon van der Pol, Piero Olliaro, Sabine Dittrich, Juvenal Nkeramahame, Maarten J Postma, Cornelis Boersma, Antoinette D I van Asselt
Cost-Effectiveness of Test-and-Treat Strategies to Reduce the Antibiotic Prescription Rate for Acute Febrile Illness in Primary Healthcare Clinics in Africa. Applied health economics and health policy 22 (5) (2024)
Maryia Zhdanava, Jacqueline Pesa, Porpong Boonmak, Samuel Schwartzbein, Qian Cai, Dominic Pilon, Zia Choudhry, Marie-Hélène Lafeuille, Patrick Lefebvre, Nizar Souayah
Predictors of High Healthcare Cost Among Patients with Generalized Myasthenia Gravis: A Combined Machine Learning and Regression Approach from a US Payer Perspective. Applied health economics and health policy 22 (5) (2024)
Rituparna Basu, Simon Eggington, Natalie Hallas, Liesl Strachan
Are Medical Device Characteristics Included in HTA Methods Guidelines and Reports? A Brief Review. Applied health economics and health policy 22 (5) (2024)